Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sichuan Haihui Pharmaceutical is a specialized pharmaceutical company based in Sichuan, China, primarily focused on the research, development, and large-scale manufacturing of high-quality chemical drugs. As a key subsidiary of the Sichuan Kelun Pharmaceutical Group, the company operates advanced production facilities that comply with international GMP standards, specializing in anti-infectives, cardiovascular treatments, and gastrointestinal medications. Its portfolio includes a wide range of finished dosage forms such as tablets, capsules, and granules, with a strong emphasis on cephalosporins and quinolone antibiotics. The company serves as a critical manufacturing hub within the Kelun Group, supporting both domestic supply and international export initiatives.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Sichuan Haihui Pharmaceutical.